• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • News
      All News Research Reports
    • Reports

    P
    Pharmaceuticals & Biotech.
    SECTOR | 02 Dec 2021

    Rs150bn incentives for drug manufacturers

    buy
    Pharmaceuticals & Biotech.
    by ICICI Securities Limited
    ICICI Securities Limited
    Indian government has announced Production Linked Incentive (PLI) Scheme of Rs150bn to incentivise Pharmaceuticals Industry to enhance India’s manufacturing capabilities. The scheme will provide financial support on incremental sales (over the base year - FY20) of pharma goods, based on pre-defined selection criteria.
    Copy Link Share on Share on Share on Share on
    Alert  
    Axis Direct released a Sector Update report for Pharmaceuticals & Biotech. on 09 Jul, 2025.
    More from Pharmaceuticals & Biotech.
    Recommended
    Five Interesting Stocks Today - July 11, 2025
    The Baseline | 11 Jul 2025, 06:25PM
    Market closes lower, Mahindra Logistics to raise Rs 750 crore via rights issue
    Trendlyne Marketwatch | 11 Jul 2025
    Volume-led growth, price stabilization and new US launches boost Indian pharma
    | 25 Mar 2024
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd